MagnaPhos 121.25mg/5ml (5mmol/5ml) oral solution
BNF presentation 0905013G0BGADDF within chapter Nutrition and Blood. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0905013G0BGADDF
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
94
NHS spend (£)
£17,133.83
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 15 |
| December 2024 | 2 |
| November 2024 | 14 |
| October 2024 | 20 |
| July 2024 | 17 |
| May 2024 | 4 |
| July 2021 | 4 |
| June 2021 | 1 |
| December 2020 | 7 |
| November 2020 | 10 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 6 | No data available |
|
Marriott's Medical Practices
ODS D82024
|
5 | 26A - NORFOLK AND WAVENEY ICB |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 3 | No data available |